We are witnessing a significant industrial transformation driven by the adoption of digital tools to manage increasing data volumes and automation to streamline workflows. However, inefficiencies in process development and data management continue to pose major challenges. These challenges are magnified by the complexities of scaling biologics production and ensuring consistency across global teams. Digital tools present an opportunity to improve efficiency and enable remote monitoring of your bioreactor cultures. Introducing BioNsight cloud, a true cloud-based software solution for bioprocess monitoring and analysis. It is fully integrated into the Eppendorf bioprocess control software DASware® control 6 and also features DataHowLab, an innovative AI-enabled analytics solution to save time and resources during process development.
BioNsight® cloud: Effortless from data to insights
ProductsWe are witnessing a significant industrial transformation driven by the adoption of digital tools to manage increasing data volumes and automation to streamline workflows. However, inefficiencies in process development and data management continue to pose major challenges. These challenges are magnified by the complexities of scaling biologics production and ensuring consistency across global teams. Digital tools present an opportunity to improve efficiency and enable remote monitoring of your bioreactor cultures. Introducing BioNsight cloud, a true cloud-based software solution for bioprocess monitoring and analysis. It is fully integrated into the Eppendorf bioprocess control software DASware® control 6 and also features DataHowLab, an innovative AI-enabled analytics solution to save time and resources during process development.
EC launches EU Biotech and Biomanufacturing Hub
Latest NewsOne day after presenting its competition strategy, the EU Commission has launched an EU Biotech and Biomanufacturing Hub. The collection of information is intended to help biotech start-ups navigate through the jungle of EU funding measures and provide access to networks that help with patenting, product authorisation and compliance with EU regulations.
Green Biotech Fund surges past €150M target
Latest NewsDutch venture capital firm Forbion revealed that its BioEconomy Fund I has amassed €164.5m. This surpasses the fund’s initial target of €150m, highlighting the increasing interest from investors in the commercial viability of biotech solutions that tackle worldwide sustainability issues.
Fueling innovation with accessible mRNA products
slider, Sponsored PublicationsThrough a new partnership with VWR, TriLink Biotechnologies has made its catalogue of industry-leading nucleic acid technologies more available in Europe. By improving the ordering process and reducing lead times, this partnership will support early-phase researchers and established commercial clients with cutting-edge mRNA products.
FDA greenlights expanded use of Ozempic
Latest NewsThe FDA has approved Novo Nordisk’s blockbuster drug Ozempic (semaglutide) for patients with chronic kidney disease who also have type 2 diabetes.
Systemic Bio wins SLAS Innovation Award 2025
Associations, Latest NewsThis year’s US$10,000 Innovation Award for the most relevant automation technology presentation at SLAS 2025 goes to Taci Pereira, CEO of Systemic Bio from Houston. She prevailed against nine finalists at the important automation conference SLAS 2025 in San Diego.
Three start-ups grab SLAS New Product Award
Associations, Latest NewsThe British company Semarion Ltd and US start-ups n6 Tec Inc and Portal Biotechnologies Inc were honoured with the New Product Award at the SLAS Conference 2025 in San Diego. The award, presented by the Society for Automation & Drug Screening, recognises pioneering technologies with the potential to transform the industry.
InSimili wins SLAS Ignite Award
Associations, Latest NewsItalian InSimili Srl has been awarded the Ignite Award for the most innovative start-up company in the lab automation sector. The US$5,000 prize was presented by the Society for Laboratory Automation and Screening (SLAS) to the company at SLAS 2025, the leading international conference for lab automation and drug screening
SLAS: automation start ups set to enable P4 medicine
Associations, Latest NewsOn the second day of SLAS 2025, the world’s largest laboratory automation conference in San Diego, the last two finalists of the Ignite Award pitched their business models. Meanwhile, the 10 finalists of the SLAS New Product Award showcased their systems in the Innovation AveNEW area of the exhibition.
Commit Biologics raises additional €5.5m seed financing
Latest NewsDenmark’s complement system activator specialist Commit Biologics A/S has added a €5.5m extension to its €16.5 seed financing. New investor Korys joined Novo Holdings and Bioqube Ventures.